Short Interest in Idorsia Ltd (OTCMKTS:IDRSF) Drops By 14.6%

Idorsia Ltd (OTCMKTS:IDRSF) saw a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 9,112,700 shares, a decrease of 14.6% from the February 29th total of 10,667,300 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 91,127.0 days.

Idorsia Stock Performance

IDRSF remained flat at $2.64 during midday trading on Monday. The company has a fifty day moving average of $1.83 and a two-hundred day moving average of $2.27. Idorsia has a one year low of $1.40 and a one year high of $11.35.

Idorsia Company Profile

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.